Bioproduction of Antibody-Drug Conjugate Payload Precursors by Engineered Cell Factories.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Trends in Biotechnology

• Publication date

  2017-05-01

• Fields of study

  Medicine, Computer Science, Engineering

• Identifiers
  DOI 10.1016/j.tibtech.2017.03.001PMID 28363408
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of the Methylmalonyl-CoA Metabolic Pathway on Ansamitocin Production in Actinosynnema pretiosum

  2017cited by this paper
• Effects of major nutrients, growth regulators and inoculum size on enhanced growth and camptothecin production in adventitious root cultures of Ophiorrhiza mungos L.

  2017cited by this paper
• Antibody-drug conjugates—an emerging class of cancer treatment

  2016cited by this paper
• Corrigendum: Recent advances in the construction of antibody-drug conjugates.

  2016cited by this paper
• Recent progress in therapeutic natural product biosynthesis using Escherichia coli.

  2016cited by this paper
• Effect of fermentation parameters, elicitors and precursors on camptothecin production from the endophyte Fusarium solani.

  2016cited by this paper
• Effects of modulation of pentose-phosphate pathway on biosynthesis of ansamitocins in Actinosynnema pretiosum.

  2016cited by this paper
• Expanding the Reach of Antibody-Drug Conjugates.

  2016cited by this paper
• CRISPR/Cas9 advances engineering of microbial cell factories.

  2016cited by this paper
• Overexpression of a pathway specific negative regulator enhances production of daunorubicin in bldA deficient Streptomyces peucetius ATCC 27952.

  2016cited by this paper
• Improved production of cytotoxic thailanstatins A and D through metabolic engineering of Burkholderia thailandensis MSMB43 and pilot scale fermentation

  2016cited by this paper
• Recent advances in the construction of antibody-drug conjugates.

  2016cited by this paper
• Cell line selection combined with jasmonic acid elicitation enhance camptothecin production in cell suspension cultures of Ophiorrhiza mungos L

  2016cited by this paper
• Overproduction of lactimidomycin by cross-overexpression of genes encoding Streptomyces antibiotic regulatory proteins

  2016cited by this paper
• Bioprospecting for Bioactive Actinomycetes from Patagonia

  2016cited by this paper
• Antibody Drug Conjugates for Cancer Therapy

  2016cited by this paper
• Natural Product Splicing Inhibitors: A New Class of Antibody-Drug Conjugate (ADC) Payloads.

  2016cited by this paper
• Overcoming heterologous protein interdependency to optimize P450-mediated Taxol precursor synthesis in Escherichia coli

  2016cited by this paper
• Abstract 2970: MEDI4276, a HER2-targeting antibody tubulysin conjugate, displays potent invitroandin vivoactivity in preclinical studies

  2016cited by this paper
• Production of Useful Terpenoids by Higher-Fungus Cell Factory and Synthetic Biology Approaches.

  2016cited by this paper
• Biosynthetic engineering and fermentation media development leads to gram-scale production of spliceostatin natural products in Burkholderia sp.

  2016cited by this paper
• Light quality modifies camptothecin production and gene expression of biosynthesis in Camptotheca acuminata Decne seedlings

  2015cited by this paper
• Enhancement of UDPG synthetic pathway improves ansamitocin production in Actinosynnem pretiosum

  2015cited by this paper
• Paired-termini antisense RNA mediated inhibition of DoxR in Streptomyces peucetius ATCC 27952

  2015cited by this paper
• Enhanced camptothecin production by ethanol addition in the suspension culture of the endophyte, Fusarium solani.

  2015cited by this paper
• Engineered biosynthesis of natural products in heterologous hosts.

  2015cited by this paper
• Multigene Editing in the Escherichia coli Genome via the CRISPR-Cas9 System

  2015cited by this paper
• Design, Synthesis, and Evaluation of Linker-Duocarmycin Payloads: Toward Selection of HER2-Targeting Antibody-Drug Conjugate SYD985.

  2015cited by this paper
• Co-overexpression of geraniol-10-hydroxylase and strictosidine synthase improves anti-cancer drug camptothecin accumulation in Ophiorrhiza pumila

  2015cited by this paper
• Distributing a metabolic pathway among a microbial consortium enhances production of natural products

  2015cited by this paper
• De novo production of the plant-derived alkaloid strictosidine in yeast

  2015cited by this paper
• Vintafolide: a novel targeted agent for epithelial ovarian cancer.

  2014cited by this paper
• Effect of Chromium on Antioxidant Potential of Catharanthus roseus Varieties and Production of Their Anticancer Alkaloids: Vincristine and Vinblastine

  2014cited by this paper
• Significance of agitation-induced shear stress on mycelium morphology and lavendamycin production by engineered Streptomyces flocculus

  2014cited by this paper
• Characterization of negative regulatory genes for the biosynthesis of rapamycin in Streptomyces rapamycinicus and its application for improved production

  2014cited by this paper
• Characterization of dephosphocoenzyme A kinase from Streptomyces peucetius ATCC27952, and its application for doxorubicin overproduction.

  2014cited by this paper
• Process optimization with alternative carbon sources and modulation of secondary metabolism for enhanced ansamitocin P-3 production in Actinosynnema pretiosum.

  2014cited by this paper
• Abstract 2904: SN-38 antibody-drug conjugates as a novel platform for solid cancer therapy: preclinical science

  2014cited by this paper
• Ultrasound assisted production of daunorubicin: Process intensification approach

  2014cited by this paper
• Coupling deep transcriptome analysis with untargeted metabolic profiling in Ophiorrhiza pumila to further the understanding of the biosynthesis of the anti-cancer alkaloid camptothecin and anthraquinones.

  2013cited by this paper
• Genomics-guided discovery of thailanstatins A, B, and C As pre-mRNA splicing inhibitors and antiproliferative agents from Burkholderia thailandensis MSMB43.

  2013cited by this paper
• Deciphering and engineering of the final step halogenase for improved chlortetracycline biosynthesis in industrial Streptomyces aureofaciens.

  2013cited by this paper
• Engineering precursor metabolite pools for increasing production of antitumor mithramycins in Streptomyces argillaceus.

  2013cited by this paper
• CRISPR interference (CRISPRi) for sequence-specific control of gene expression

  2013cited by this paper
• Multiplex Genome Engineering Using CRISPR/Cas Systems

  2013cited by this paper
• Natural Product Cytotoxins as Payloads for Antibody Drug Conjugates

  2013cited by this paper
• Emerging monoclonal antibodies and related agents for the treatment of chronic lymphocytic leukemia.

  2013cited by this paper
• Culture medium optimization for camptothecin production in cell suspension cultures of Nothapodytes nimmoniana (J. Grah.) Mabberley

  2013cited by this paper
• Molecular Regulation of Antibiotic Biosynthesis in Streptomyces

  2013cited by this paper
• An Insight into the “-Omics” Based Engineering of Streptomycetes for Secondary Metabolite Overproduction

  2013cited by this paper
• Camptothecin-producing endophytic fungus Trichoderma atroviride LY357: isolation, identification, and fermentation conditions optimization for camptothecin production

  2013cited by this paper
• Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems

  2013cited by this paper
• SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML.

  2013cited by this paper
• Diversity of endophytic fungi and screening of fungal paclitaxel producer from Anglojap yew, Taxus x media

  2013cited by this paper
• Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody–drug conjugate in development for the treatment of HER2-positive cancer

  2012cited by this paper
• Mining the Biodiversity of Plants: A Revolution in the Making

  2012cited by this paper
• Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.

  2012cited by this paper
• Maintenance of membrane integrity and increase of taxanes production in hazel (Corylusavellana L.) cells induced by low-intensity ultrasound

  2012cited by this paper
• Overexpression of ORCA3 and G10H in Catharanthus roseus Plants Regulated Alkaloid Biosynthesis and Metabolism Revealed by NMR-Metabolomics

  2012cited by this paper
• Phase I study of anti‐CD22 immunoconjugate inotuzumab ozogamicin plus rituximab in relapsed/refractory B‐cell non‐Hodgkin lymphoma

  2012cited by this paper
• Heterologous expression and genetic engineering of the tubulysin biosynthetic gene cluster using Red/ET recombineering and inactivation mutagenesis.

  2012cited by this paper
• Anti CD-30 Antibody-Drug Conjugate Brentuximab Vedotin (ADCETRIS®) May Be a Promising Treatment Option for Systemic Mastocytosis (SM).

  2012cited by this paper
• Enhancement of camptothecin production in Camptotheca acuminata hairy roots by overexpressing ORCA3 gene

  2011cited by this paper
• The regulation of the secondary metabolism of Streptomyces: new links and experimental advances.

  2011cited by this paper
• Enhanced production of ansamitocin P-3 by addition of Mg2+ in fermentation of Actinosynnema pretiosum.

  2011cited by this paper
• Proteomic approach to enhance doxorubicin production in panK-integrated Streptomyces peucetius ATCC 27952

  2011cited by this paper
• Enhanced production of ansamitocin P-3 by addition of isobutanol in fermentation of Actinosynnema pretiosum.

  2011cited by this paper
• Isolation and genetic manipulation of the antibiotic down-regulatory gene, wblA ortholog for doxorubicin-producing Streptomyces strain improvement

  2010cited by this paper
• Effect of plant growth regulators on the biosynthesis of vinblastine, vindoline and catharanthine in Catharanthus roseus

  2010cited by this paper
• Synthesis and preliminary biological evaluation of high-drug-load paclitaxel-antibody conjugates for tumor-targeted chemotherapy.

  2010cited by this paper
• Self-resistance mechanism in Streptomyces peucetius: overexpression of drrA, drrB and drrC for doxorubicin enhancement.

  2010cited by this paper
• Novel immunoconjugates comprised of streptonigrin and 17-amino-geldanamycin attached via a dipeptide-p-aminobenzyl-amine linker system.

  2009cited by this paper
• Constitutive overexpression of asm2 and asm39 increases AP-3 production in the actinomycete Actinosynnema pretiosum

  2009cited by this paper
• Enhancement of doxorubicin production by expression of structural sugar biosynthesis and glycosyltransferase genes in Streptomyces peucetius.

  2009cited by this paper
• Reassembly of Anthramycin Biosynthetic Gene Cluster by Using Recombinogenic Cassettes

  2008cited by this paper
• Interspecies DNA Microarray Analysis Identifies WblA as a Pleiotropic Down-Regulator of Antibiotic Biosynthesis in Streptomyces

  2007cited by this paper
• Responses of defense signals, biosynthetic gene transcription and taxoid biosynthesis to elicitation by a novel synthetic jasmonate in cell cultures of Taxus chinensis

  2006cited by this paper
• Production of Ansamycin Polyketide Precursors in Escherichia coli

  2006cited by this paper
• Construction of asm2 Deletion Mutant of Actinosynnema pretiosum and Medium Optimization for Ansamitocin P-3 Production Using Statistical Approach

  2006cited by this paper
• Novel chemically synthesized hydroxyl‐containing jasmonates as powerful inducing signals for plant secondary metabolism

  2004cited by this paper
• Engineered biosynthesis of an ansamycin polyketide precursor in Escherichia coli

  2003cited by this paper
• Effective production of amanitins by two-step cultivation of the basidiomycete, Galerina fasciculata GF-060.

  2000cited by this paper
• Duocarmycins, new antitumor antibiotics produced by Streptomyces; producing organisms and improved production.

  1991cited by this paper
• Secondary metabolism in microorganisms, plants and animals, M. Luckner (Ed.). Springer-Verlag, New York (1984)

  1985cited by this paper
• Special Topic: Biosynthesis and Regulation of Secondary Metabolites in Microorganisms Asm8, a Specific Lal-type Activator of 3-amino-5-hydroxy- Benzoate Biosynthesis in Ansamitocin Production

  year unknowncited by this paper

• New Technologies Bloom Together for Bettering Cancer Drug Conjugates

  2022cites this paper
• New Technologies Bloom Together for Bettering Cancer Drug Conjugates

  2022cites this paper
• Plant-made immunotoxin building blocks: A roadmap for producing therapeutic antibody-toxin fusions.

  2020cites this paper
• Stressing the Role of DNA as a Drug Carrier: Synthesis of DNA–Drug Conjugates through Grafting Chemotherapeutics onto Phosphorothioate Oligonucleotides

  2019cites this paper
• Exploring antimicrobials from the flora and fauna of marine: Opportunities and limitations.

  2019cites this paper
• Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy

  2018cites this paper
• Rational approach to improve ansamitocin P‐3 production by integrating pathway engineering and substrate feeding in Actinosynnema pretiosum

  2018cites this paper
• Genome-Scale Metabolic Model of Actinosynnema pretiosum ATCC 31280 and Its Application for Ansamitocin P-3 Production Improvement

  2018cites this paper
• A developed antibody–drug conjugate rituximab-vcMMAE shows a potent cytotoxic activity against CD20-positive cell line

  2018cites this paper
• Combination of traditional mutation and metabolic engineering to enhance ansamitocin P‐3 production in Actinosynnema pretiosum

  2017cites this paper
• Book Review: Antibody-Drug Conjugates: Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer

  2017cites this paper